Insider Trading Alert - MGLN, AZZ And DY Traded By Insiders

Stocks with insider trader activity include MGLN, AZZ and DY
By TheStreet Wire ,

Friday, July 15, 2016, 37 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $87.69 to $104,800,000.00.

Highlighted Stocks Traded by Insiders:

Magellan Health (MGLN) - FREE Research Report

West Jeffrey N, who is SVP & Controller at Magellan Health, bought 267 shares at $51.99 on July 15, 2016. Following this transaction, the SVP & Controller owned 11,375 shares meaning that the stake was boosted by 2.4% with the 267-share transaction.

The shares most recently traded at $68.86, up $16.87, or 24.5% since the insider transaction. Historical insider transactions for Magellan Health go as follows:

  • 4-Week # shares bought: 105
  • 4-Week # shares sold: 18,400
  • 12-Week # shares bought: 105
  • 12-Week # shares sold: 18,400
  • 24-Week # shares bought: 105
  • 24-Week # shares sold: 18,400

The average volume for Magellan Health has been 201,400 shares per day over the past 30 days. Magellan Health has a market cap of $1.7 billion and is part of the health care sector and health services industry. Shares are up 11.47% year-to-date as of the close of trading on Friday.

Magellan Health, Inc. engages in the healthcare management business in the United States. The company has a P/E ratio of 72.7. Currently, there is 1 analyst who rates Magellan Health a buy, 1 analyst rates it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on MGLN - FREE

TheStreet Quant Ratings

rates Magellan Health as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, increase in net income and growth in earnings per share. We feel its strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full

Magellan Health Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

AZZ (AZZ) - FREE Research Report

Eisman Wallace P, who is Director at AZZ, bought 1,000 shares at $62.27 on July 15, 2016. Following this transaction, the Director owned 4,641 shares meaning that the stake was boosted by 27.46% with the 1,000-share transaction.

The shares most recently traded at $62.52, up $0.25, or 0.4% since the insider transaction. Historical insider transactions for AZZ go as follows:

  • 4-Week # shares bought: 1,553
  • 4-Week # shares sold: 2,762
  • 12-Week # shares bought: 1,553
  • 12-Week # shares sold: 2,762
  • 24-Week # shares bought: 1,553
  • 24-Week # shares sold: 2,762

The average volume for AZZ has been 128,100 shares per day over the past 30 days. AZZ has a market cap of $1.6 billion and is part of the industrial goods sector and industrial industry. Shares are up 12.06% year-to-date as of the close of trading on Friday.

AZZ incorporated provides galvanizing services, welding solutions, specialty electrical equipment, and engineered services to the power generation, transmission, distribution, and industrial markets. The company operates through two segments, Energy and Galvanizing Services. The stock currently has a dividend yield of 0.96%. The company has a P/E ratio of 20.8. Currently, there are no analysts who rate AZZ a buy, no analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on AZZ - FREE

TheStreet Quant Ratings

rates AZZ as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, good cash flow from operations, solid stock price performance and growth in earnings per share. We feel its strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full

AZZ Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Dycom Industries (DY) - FREE Research Report

Estes Timothy R, who is Executive VP & COO at Dycom Industries, sold 10,000 shares at $96.03 on July 15, 2016. Following this transaction, the Executive VP & COO owned 233,812 shares meaning that the stake was reduced by 4.1% with the 10,000-share transaction.

Dickens Kimberly L, who is VP & Chief HR Officer at Dycom Industries, sold 1,661 shares at $95.87 on July 15, 2016. Following this transaction, the VP & Chief HR Officer owned 5,439 shares meaning that the stake was reduced by 23.39% with the 1,661-share transaction.

The shares most recently traded at $94.82, down $1.05, or 1.11% since the insider transaction. Historical insider transactions for Dycom Industries go as follows:

  • 4-Week # shares bought: 2,500
  • 4-Week # shares sold: 31,940
  • 12-Week # shares bought: 2,500
  • 12-Week # shares sold: 31,940
  • 24-Week # shares bought: 2,500
  • 24-Week # shares sold: 31,940

The average volume for Dycom Industries has been 638,900 shares per day over the past 30 days. Dycom Industries has a market cap of $3.0 billion and is part of the industrial goods sector and materials & construction industry. Shares are up 35.58% year-to-date as of the close of trading on Friday.

Dycom Industries, Inc. provides specialty contracting services in the United States and Canada. The company has a P/E ratio of 28.4. Currently, there are 8 analysts who rate Dycom Industries a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on DY - FREE

TheStreet Quant Ratings

rates Dycom Industries as a

buy

. The company's strengths can be seen in multiple areas, such as its robust revenue growth, notable return on equity, solid stock price performance, impressive record of earnings per share growth and compelling growth in net income. We feel its strengths outweigh the fact that the company shows weak operating cash flow. Get the full

Dycom Industries Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Loading ...